XML 52 R39.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock-Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense
Stock-based compensation expense is recognized in cost of revenues, corporate technology and production systems, and selling, general and administrative expense in the accompanying unaudited condensed consolidated statements of operations and comprehensive loss as follows:
 Three Months Ended
March 31,
(in thousands)20242023
Stock-based compensation expense
Cost of revenues$359 $428 
Corporate technology and production systems819 612 
Selling, general and administrative8,164 7,003 
Total stock-based compensation expense$9,342 $8,043 
Schedule of Share-based Payment Arrangement, Option, Activity
The table below provides a summary of SVOs and PSOs currently outstanding under the 2015 Plan for the three months ended March 31, 2024:
Outstanding SVOsOutstanding PSOs
Number of
Shares		Weighted
Average
Exercise
Price		Weighted
Average
Remaining
Contractual
Life
(years)		Aggregate
Intrinsic
Value		Number of
Shares		Weighted
Average
Exercise
Price		Weighted
Average
Remaining
Contractual
Life
(years)		Aggregate
Intrinsic
Value
(in thousands, except shares and per share amounts)
Balances as of December 31, 20235,635,742 $9.60 3.68$24,349 3,036,930 $10.05 2.14$11,732 
Granted— — — — 
Forfeited / Expired(17,970)9.68 112 — — 
Exercised(1,555,977)9.63 8,503 (1,841,326)10.30 10,482 
Balances as of March 31, 2024(1)
4,061,795 $9.59 4.33$26,373 1,195,604 $9.68 4.85$7,648 
_________________________
(1)    All SVOs and PSOs are exercisable as of March 31, 2024.
The table below provides a summary of stock option activity under the 2021 Equity Plan for the three months ended March 31, 2024:
Number of SharesWeighted Average Exercise PriceWeighted Average Contractual Term (in years)Aggregate Intrinsic Value
Outstanding as of December 31, 20234,558,199 $21.14 8.06$904 
Granted— — 
Forfeited / Expired(11,724)23.00 
Exercised — — 
Outstanding as of March 31, 20244,546,475 $21.09 7.79$2,629 
Exercisable as of March 31, 20241,974,043 $22.01 7.63$593 
Schedule of Restricted Stock Activity
The table below provides a summary of restricted stock activity under the 2021 Equity Plan for the three months ended March 31, 2024:
Number of SharesWeighted Average Fair Value
(per share)
Unvested as of December 31, 20233,796,203 $16.40 
Granted1,958,874 15.92 
Forfeited / Cancelled(74,354)17.45 
Vested(591,611)10.92 
Unvested as of March 31, 20245,089,112 $16.39 
The table below provides a summary of RSU activity under the 2021 Equity Plan for the three months ended March 31, 2024:
Number of SharesWeighted Average Fair Value
(per share)
Unvested as of December 31, 2023120,555 $15.82 
Granted6,347 15.92 
Forfeited / Cancelled(18,925)13.30 
Vested(5,268)9.82 
Unvested as of March 31, 2024102,709 $16.33